Ivermectin, the anti-parasitic drug, has been widely used in India and many other countries as an off-label medication to treat COVID-19 mild and moderate COVID-19 patients, despite limited evidence of its efficacy.
The European Medicines Agency (EMA), which regulates drugs in the EU, on March 2